Perceptions about levels of harmful chemicals in e-cigarettes relative to cigarettes, and associations with relative e-cigarette harm perceptions, e-cigarette use and interest.


Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
10 2023
Historique:
received: 16 11 2022
accepted: 25 04 2023
pmc-release: 01 10 2024
medline: 7 9 2023
pubmed: 23 5 2023
entrez: 23 5 2023
Statut: ppublish

Résumé

Exposure to chemicals contributes to harm from nicotine products, and e-cigarette communications often refer to chemicals. However, while e-cigarette studies commonly measure perceived harmfulness of e-cigarettes relative to cigarettes, few have assessed comparative perceptions about chemicals. This study measured perceived levels of harmful chemicals in e-cigarettes compared with cigarettes and associations with e-cigarette/cigarette relative harm perceptions, e-cigarette use and interest. This was an on-line cross-sectional survey of adults/young adults from a nationally representative research panel in the United States conducted in January 2021. Participants were independent samples of 1018 adults who smoked cigarettes and 1051 young adult non-smokers (aged 18-29 years). Participants were asked their perceptions of the level of harmful chemicals in e-cigarettes versus cigarettes (fewer/about the same/more/do not know), perceived harmfulness of using e-cigarette versus cigarettes (less/about the same/more/do not know) and their current e-cigarette use and use interest. Approximately 20% of all participants (18.1% of adult smokers, and 21.0% of young adult non-smokers) believed e-cigarettes contain fewer harmful chemicals than cigarettes, while 35.6% of adult smokers and 24.9% of young adult non-smokers responded 'do not know'. Participants more frequently reported 'do not know' to the chemicals item than the harm item. Approximately half (51.0-55.7%) of those who believed e-cigarettes contain fewer harmful chemicals also believed e-cigarettes are less harmful than cigarettes. Both beliefs were associated with higher odds of interest in using e-cigarettes [less harmful belief, odds ratio (OR) = 5.53, 95% confidence interval (CI = 2.93-10.43); fewer chemicals belief, OR = 2.45, 95% CI = 1.40-4.29] and past 30-day e-cigarette use (less harmful belief, OR = 2.53, 95% CI = 1.17-5.44; fewer chemicals belief, OR = 5.09, 95% CI = 2.31-11.19) for adults who smoke, but not young adult non-smokers. In the United States, most adults who smoke cigarettes and young adult non-smokers do not appear to think that e-cigarettes have fewer harmful chemicals than cigarettes, and many are uncertain about how these levels compare.

Sections du résumé

BACKGROUND AND AIMS
Exposure to chemicals contributes to harm from nicotine products, and e-cigarette communications often refer to chemicals. However, while e-cigarette studies commonly measure perceived harmfulness of e-cigarettes relative to cigarettes, few have assessed comparative perceptions about chemicals. This study measured perceived levels of harmful chemicals in e-cigarettes compared with cigarettes and associations with e-cigarette/cigarette relative harm perceptions, e-cigarette use and interest.
DESIGN, SETTING AND PARTICIPANTS
This was an on-line cross-sectional survey of adults/young adults from a nationally representative research panel in the United States conducted in January 2021. Participants were independent samples of 1018 adults who smoked cigarettes and 1051 young adult non-smokers (aged 18-29 years).
MEASUREMENTS
Participants were asked their perceptions of the level of harmful chemicals in e-cigarettes versus cigarettes (fewer/about the same/more/do not know), perceived harmfulness of using e-cigarette versus cigarettes (less/about the same/more/do not know) and their current e-cigarette use and use interest.
FINDINGS
Approximately 20% of all participants (18.1% of adult smokers, and 21.0% of young adult non-smokers) believed e-cigarettes contain fewer harmful chemicals than cigarettes, while 35.6% of adult smokers and 24.9% of young adult non-smokers responded 'do not know'. Participants more frequently reported 'do not know' to the chemicals item than the harm item. Approximately half (51.0-55.7%) of those who believed e-cigarettes contain fewer harmful chemicals also believed e-cigarettes are less harmful than cigarettes. Both beliefs were associated with higher odds of interest in using e-cigarettes [less harmful belief, odds ratio (OR) = 5.53, 95% confidence interval (CI = 2.93-10.43); fewer chemicals belief, OR = 2.45, 95% CI = 1.40-4.29] and past 30-day e-cigarette use (less harmful belief, OR = 2.53, 95% CI = 1.17-5.44; fewer chemicals belief, OR = 5.09, 95% CI = 2.31-11.19) for adults who smoke, but not young adult non-smokers.
CONCLUSIONS
In the United States, most adults who smoke cigarettes and young adult non-smokers do not appear to think that e-cigarettes have fewer harmful chemicals than cigarettes, and many are uncertain about how these levels compare.

Identifiants

pubmed: 37218410
doi: 10.1111/add.16258
pmc: PMC10640892
mid: NIHMS1940318
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1881-1891

Subventions

Organisme : NCI NIH HHS
ID : R37 CA222002
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA229973
Pays : United States

Informations de copyright

© 2023 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Références

Tob Control. 2018 Nov;27(Suppl 1):s62-s69
pubmed: 30158212
Addict Behav. 2021 Apr;115:106778
pubmed: 33341530
Tob Control. 2019 Jul;28(4):440-448
pubmed: 30104408
Addict Behav. 2018 Apr;79:219-225
pubmed: 29175027
Addiction. 2019 Dec;114(12):2197-2205
pubmed: 31278802
Int J Environ Res Public Health. 2020 Sep 18;17(18):
pubmed: 32961924
JAMA Netw Open. 2019 Mar 1;2(3):e191047
pubmed: 30924893
Harm Reduct J. 2020 Sep 18;17(1):65
pubmed: 32948187
Prev Med Rep. 2016 Jul 10;4:309-12
pubmed: 27486560
Nicotine Tob Res. 2022 Feb 14;24(3):316-323
pubmed: 34343322
Prev Med. 2017 Mar;96:94-100
pubmed: 28034733
Addict Behav. 2019 Nov;98:106020
pubmed: 31238235
Int J Environ Res Public Health. 2019 Dec 23;17(1):
pubmed: 31878111
Tob Control. 2020 Mar;29(2):217-223
pubmed: 31040224
Public Underst Sci. 2021 Aug;30(6):777-796
pubmed: 33627027
Addict Behav. 2020 Jul;106:106337
pubmed: 32145496
Nicotine Tob Res. 2021 Oct 7;23(11):1848-1854
pubmed: 34013354
Am J Public Health. 2021 Sep;111(9):1661-1672
pubmed: 34410826
Tob Control. 2023 Aug;32(e2):e228-e235
pubmed: 35534230
Chem Res Toxicol. 2020 Oct 19;33(10):2637-2646
pubmed: 32880169
Addict Behav Rep. 2021 Dec 27;15:100404
pubmed: 35434246
Am J Prev Med. 2022 Aug;63(2):186-194
pubmed: 35868816
Nicotine Tob Res. 2020 Apr 21;22(5):747-755
pubmed: 30852611
Harm Reduct J. 2021 Sep 8;18(1):96
pubmed: 34496865
Prev Med. 2017 Mar;96:144-148
pubmed: 28024860
Am J Prev Med. 2014 Aug;47(2):141-9
pubmed: 24794422
PLoS One. 2020 Oct 21;15(10):e0240611
pubmed: 33085686
BMC Public Health. 2022 Sep 19;22(1):1771
pubmed: 36123722

Auteurs

Olivia A Wackowski (OA)

Rutgers Center for Tobacco Studies, Rutgers University, New Brunswick, NJ, USA.
Department of Health Behavior, Society, and Policy, Rutgers School of Public Health, Piscataway, NJ, USA.

Michelle T Bover Manderski (MT)

Rutgers Center for Tobacco Studies, Rutgers University, New Brunswick, NJ, USA.
Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA.

Stefanie K Gratale (SK)

Rutgers Center for Tobacco Studies, Rutgers University, New Brunswick, NJ, USA.

Caitlin V Weiger (CV)

Rutgers Center for Tobacco Studies, Rutgers University, New Brunswick, NJ, USA.

Richard J O'Connor (RJ)

Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH